"Decoupling” from China would come at the cost of American opportunity and influence, writes fellow Gabriel Collins. Instead, “de-risking” — loosening China’s grip on global supply chains without cutting ties entirely — would better serve American interests.
Hostile immigration enforcement policies and anti-immigrant actions against refugees and asylum seekers are causing trauma to migrant families and exposing them to dangerous living conditions on both sides of the U.S.-Mexico border.
Luz Maria Garcini, Kimberly Nguyen, Daniel Argueta, Aldo Barrita, Amy Barrett, Jin YanMay 25, 2023
U.S. backing of key gas infrastructure projects in Central and Eastern Europe can foster deeper market liberalization, the authors write, and make European partners more resilient against Russian energy coercion.
Gabriel Collins, Anna B. MikulskaFebruary 12, 2021
A pending bill in Congress would hobble OPEC by opening the door to anti-trust lawsuits against government-owned oil companies. This brief examines the multiple ways such legislation, known as NOPEC, would undermine critical U.S. interests. DOI: https://doi.org/10.25611/rezh-fc53
Larger trucks and SUVs with powerful, high-displacement engines are the low-hanging fruit for any policymaker seeking the most efficient path to reducing gasoline use and the associated emissions.
Fellows Gabriel Collins and Jim Krane argue in this issue brief that despite changes in U.S.-Persian Gulf trade relations, the U.S. retains an enduring interest in preserving political stability and securing oil flows from the region.
The high-growth, high-tech sector appears poised to dramatically grow. U.S. policy to support this sector could enhance and hasten its rise, or could destroy a new American dream.
To harness the power of the market for ideas, the federal government must fund the U.S. patent office to 21st century levels and enhance the rights of patent owners.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
The federal government will need a nuanced approach to properly stimulate small business growth. However, a core
focus should be on creating a level playing field for community banks to compete to provide small business loans.